Original articlesContinuous but not intermittent olanzapine infusion induces vacuous chewing movements in rats
Section snippets
Animals
Adult male Sprague-Dawley rats (Charles River, Montreal, Canada), weighing 175–200 g at the start of the experiment, were housed two per cage in 19 × 10.5 × 8 inches transparent polycarbonate cages (Lab Products, Seaforth, Delaware) and maintained on a 12-hour light/dark cycle with continuous access to food and water. All procedures were carried out in accordance with The Animals for Research Act 1968–1969 of the Province of Ontario and the Guidelines of the Canadian Council on Animal Care.
Drug treatments
In
VCM behavior
A repeated-measures analysis of variance (ANOVA) comparing VCMs between treatment groups during the 8 weeks of treatment (Figure 1) revealed a significant dose effect [F(2,248) = 7.26, p = .003], a significant time effect [F(8,248) = 5.38, p < .001], and a significant dose × time effect [F(16,248) = 4.03, p < .001]. An ANOVA comparing average VCMs between different treatment groups over the last three test sessions was also significant [F(2,33) = 4.43, p = .02]. Post hoc Bonferroni analyses
Discussion
The results of the present study demonstrate a clear association between the emergence of the VCM syndrome and continuous versus transient D2 receptor occupancy and use of the atypical antipsychotic OLZ. Animals that received OLZ via daily SC injections did not develop VCMs beyond placebo values; however, rats that received OLZ via MP (a method that gives rise to continuous D2 occupancy) developed a high level of VCMs that was comparable to the HAL-treated group.
We suggest that the reason
References (38)
- et al.
Continuous and intermittent levodopa differentially affect rotation induced by D1 and D2 dopamine agonists
Eur J Pharmacol
(1989) - et al.
Intermittent neuroleptic treatment induces long-lasting abnormal mouthing in the rat
Eur J Pharmacol
(1989) - et al.
Intermittent versus continuous neuroleptic treatment in a rat model
Eur J Pharmacol
(1990) - et al.
Dopamine D2 receptors and their role in atypical antipsychotic actionStill necessary and may even be sufficient
Biol Psychiatry
(2001) The role of serotonin in antipsychotic drug action
Neuropsychopharmacology
(1999)- et al.
The effects of raclopride on vacuous chewing movements in rats following acute administration
Physiol Behav
(1996) - et al.
The vacuous chewing movement (VCM) model of tardive dyskinesia revisitedRelationship to D2 receptor occupancy
Neurosci Biobehav Rev
(2002) Drug holidaysintermittent pharmacology for psychiatric patients
International Drug Therapy Newsletter
(1966)- et al.
Randomised double-blind comparison of the incidence of tardive dyskinesia in patients with schizophrenia during long-term treatment with olanzapine or haloperidol
Br J Psychiatry
(1999) - et al.
A 5-year prospective longitundinal study of tardive dyskinesiaFactors predicting appearance of new cases
J Clin Psychopharmacol
(1988)
Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol
Psychopharmacology
Positron emission tomographic analysis of central D1 and D2 dopamine occupancy in patients treated with classical neuroleptics and clozapineRelation to extrapyramidal side effects
Arch Gen Psychiatry
Effect of drug holidays on tardive dyskinesia.
Extrapyramidal side effects, tardive dykinesia, and the concept of atypicality
J Clin Psychiatry
Persistent vacuous chewing movements in rats following neuroleptic treatmentRelationship with dopaminergic and cholinergic function
Psychopharmacology
Intermittent neuroleptic therapy and tardive dyskinesiaa literature review
Hosp Community Psychiatry
Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an amimal model of tardive dyskinesia
Psychopharmacology
Tardive dyskinesia
Schizophr Bull
Integrating incidence and prevalence of tardive dyskinesia
Psychopharmacol Bull
Cited by (40)
Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex
2021, Behavioural Brain ResearchPharmacotherapy of schizophrenia: Mechanisms of antipsychotic accumulation, therapeutic action and failure
2021, Behavioural Brain ResearchContinuous versus extended antipsychotic dosing in schizophrenia: Less is more
2021, Behavioural Brain ResearchAntipsychotic-evoked dopamine supersensitivity
2020, NeuropharmacologyCitation Excerpt :As illustrated in Fig. 2A, this can be modelled in rats by administering antipsychotic drugs via a subcutaneously implanted osmotic minipump (Kapur et al., 2003; Samaha et al., 2007) or via a long-acting injectable formulation (Turrone et al., 2003b). Using these continuous-treatment approaches, clinically-representative doses [i.e., doses producing 65 to 80% of striatal D2 receptor occupancy (Wadenberg et al., 2000; Natesan et al., 2006)] promote dopamine supersensitivity to the behavioural effects of dopamine agonists (Ericson et al., 1996; Samaha et al., 2007, 2008; Bedard et al., 2011, 2013), tolerance to the effects of antipsychotics in tests of antipsychotic-like efficacy (Samaha et al., 2007, 2008; Amato et al., 2018), and increased probability of vacuous chewing movements (Turrone et al., 2003a; b, 2005) in laboratory rats. A different outcome emerges if clinically-representative antipsychotic doses are given regularly, but intermittently such that striatal D2 occupancy is high for a few hours following antipsychotic administration, and then decreases until the next injection [see Fig. 2B; Kapur et al. (2003)].
Dopamine, the antipsychotic molecule: A perspective on mechanisms underlying antipsychotic response variability
2018, Neuroscience and Biobehavioral ReviewsSex differences in aripiprazole sensitization from adolescence to adulthood
2017, Pharmacology Biochemistry and Behavior